From R&D to revenue: How Vanderbilt is turning greater-good research into cash
Sifting through the data of Vanderbilt University Medical Center’s 1.7 million electronic medical records, the last thing on Daniel Masys’ mind is making a buck. He’s intent on finding patterns in the EMRs of patients who have experienced bad medication side effects.
“I’m just after the science,” explained Masys, VUMC’s chair of biomedical informatics, whose work is funded by a $6.4 million grant from the National Institutes of Health. “I’ve just always been interested in trying to make the world a better place.”
But if Masys and his co-investigator hit their target — identifying common genetic markers in these patients’ DNA samples, which could be used to predict and prevent harmful reactions in others — there may be a business opportunity to license that technology or develop a commercial product.
Read the article featured in The City Paper at nashvillepost.com.
